Australia Bans Replica Versions Of Popular Weight-Loss Drugs From Novo Nordisk, Eli Lilly On Safety Concerns
Australia announced on Wednesday that it would ban compounded versions of weight-loss drugs like Novo Nordisk A/S’s NVO Ozempic and Eli Lilly And Co’s LLY Mounjaro, citing safety concerns. Recently, the Chinese regulatory authority approved Eli Lilly’ …